ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2317

Preliminary Validation of a Magnetic Resonance Imaging-Based Inflammatory Scoring System in Adult Myositis

Nicolo Pipitone1, Antonella Notarnicola2,3, Arnaldo Scardapane4, Lucia Spaggiari5, Gabriele Levrini6, Florenzo Iannone7, Carlo Salvarani8, Giovanni Lapadula9, Ingrid E. Lundberg2, Pierpaolo Pattacini10 and Giulio Zuccoli11, 1Rheumatology, Arcispedale S. M. Nuova, Reggio Emilia, Italy, 2Department of Medicine, Rheumatology Unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 3Rheumatology, Bari University, Bari, Italy, 4Radiology, University of Bari, Bari, Italy, 5Radiology, Arcispedale S Maria Nuova, IRCCS, Reggio Emilia, Italy, 6Arcispedale S Maria Nuova, Reggio Emilia, Italy, 7Bari University, Rheumatology, Bari, Italy, 8Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, Italy, 9Rheumatology Unit, University of Bari, Bari, Italy, 10Radiology, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy, 11Children's Hospital of Pittsburgh, Pittsburgh, PA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: dermatomyositis, Magnetic resonance imaging (MRI), myositis and polymyositis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Muscle Biology, Myositis and Myopathies - Poster II: Clinical

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: in patients with active myositis, magnetic resonance imaging (MRI) often demonstrates muscle edema thought to represent active inflammation. An MRI-based muscle inflammatory scoring system has been validated for juvenile myositis (Rheumatology 2011; 50:2237), but to the best of our knowledge there is no such a scoring system for adult myositis. We aimed to validate an MRI-based edema score for patients with adult myositis.

Methods: twenty-one patients (9 polymyositis [PM], 12 dermatomyositis diagnosed according to Bohan and Peter criteria) were included in the study. In 8/9 patients with PM the diagnosis was confirmed by consistent histology. MRI of the thigh and pelvic floor muscles was performed on a 1.0 or 1.5T scanner using a surface coil. Edema (1= present, 0= absent) was assessed by fat-suppressed sequences in 17 thigh and pelvic floor muscles and a score (0-17) was calculated by adding the separate muscle scores by three blinded independent observers. Sensitivity to change was assessed by sign test. Muscle strength was evaluated in 12 muscle groups by manual muscle test (MMT) and graded according to the extended Medical Research Council scale (0-5). Serum creatine kinase (CK) levels were measured (U/l) and MMT performed simultaneously or within a week from the MRI study in each patient.

Results:  38 MRI scans were available from 21 patients. 10 patients had new onset of myositis. Two patients had 4 scans, 1 had 3 scans, 9 had 2 scans, and 9 had 1 scan each. The median MRI edema score was 2.7 and the interquartile range (IQR) 8.96. Inter-rater Cronbach’s alpha was 0.984, while single-measure intraclass correlation coefficient (ICC) was 0.954 (95% confidence interval [CI] 0.922-0.974). Bland-Altman’s plot showed no significant differences between raters. Two raters evaluated the same MRI exams on 2 different time points to determine intra-rater variability. Cronbach’s alpha was 0.903 and 0.921, while single-measure ICC was 0.815 (95% CI 0.667-0.901) and 0.851 (95% CI 0.729-0.921) for rater 1 and 2, respectively. In 7 patients for whom a repeat MRI after treatment onset was available median edema score decreased from a median of 8.83 (IQR 9.18) to 0.71 (IQR 12.3) (p 0.07). MRI edema score did not correlate with serum CK levels (median 384, IQR 1317) or MMT (median 4.39, IQR 0.45) (p>0.05 Spearman’s rho).

Conclusion:  the MRI edema score presented herein is highly reproducible with good inter- and intra-rater variability and appears to be sensitive to change. The significant lack of correlation of MRI edema score with serum CK levels and MMT suggests that these measures of myositis activity may be at least partially uncoupled, suggesting that MRI score adds information on disease activity above the CK and MMT, although the small sample size hampers a confident conclusion in this regard.


Disclosure: N. Pipitone, None; A. Notarnicola, None; A. Scardapane, None; L. Spaggiari, None; G. Levrini, None; F. Iannone, None; C. Salvarani, None; G. Lapadula, None; I. E. Lundberg, None; P. Pattacini, None; G. Zuccoli, None.

To cite this abstract in AMA style:

Pipitone N, Notarnicola A, Scardapane A, Spaggiari L, Levrini G, Iannone F, Salvarani C, Lapadula G, Lundberg IE, Pattacini P, Zuccoli G. Preliminary Validation of a Magnetic Resonance Imaging-Based Inflammatory Scoring System in Adult Myositis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/preliminary-validation-of-a-magnetic-resonance-imaging-based-inflammatory-scoring-system-in-adult-myositis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/preliminary-validation-of-a-magnetic-resonance-imaging-based-inflammatory-scoring-system-in-adult-myositis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology